Aijaz_Kamran 2024
Complete Response to Pembrolizumab in Stage IV
Alveolar Soft Part Sarcoma After Failure of Four
Lines of Treatment: A Case Report and Literature
Review
Nishikawa_Yonemori 2024
Efficacy and safety of nivolumab monotherapy in patients
with unresectable clear cell sarcoma and alveolar soft part
sarcoma (OSCAR Trial/NCCH1510)
Tan_Liu 2024
Anlotinib plus TQB2450, a PD-L1 Antibody, in Patients with
Advanced Alveolar Soft Part Sarcoma: A Single-Arm, Phase II
Trial
Mondaza-Hernandez_Martin-Broto 2024
Exploratory analysis of immunomodulatory
factors identifies L1CAM as a prognostic
marker in alveolar soft-part sarcoma
Lee_Bui 2025
Histologic and Immunologic Factors Associated with
Response to Immune Checkpoint Inhibitors in Advanced
Sarcoma
SÖYLEMEZ_ŞANLI 2025
Response rates of pazopanib therapy in metastatic
soft tissue sarcoma using real‑world data
Cao_Liu 2025
Efficacy of immune checkpoint inhibitors in the treatment of soft tissue
sarcoma: A systematic review and meta-analysis of clinical trials
Goldberg_Dranoff 2015
Biologic Activity of Autologous, Granulocyte-Macrophage
Colony Stimulating Factor Secreting Alveolar Soft Parts
Sarcoma and Clear Cell Sarcoma Vaccines
Pappo_Pratt 1996
Alveolar Soft Part Sarcoma in Children and Adolescents: Clinical Features and
Outcome of 11 Patients
Bisogno_Carli 2004
Interferon Alpha for Alveolar Soft Part Sarcoma